However, PABPN1 aggregates are detected in a much higher percentage of myonuclei in A17.1 mice than in biopsies from individuals with OPMD, likely due to overexpression of the constitutively active A17.1 transgene. This evidence concerns the gene PABPN1 and oculopharyngeal muscular dystrophy.